Correlation Between ScanSource and Inhibrx
Can any of the company-specific risk be diversified away by investing in both ScanSource and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ScanSource and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ScanSource and Inhibrx, you can compare the effects of market volatilities on ScanSource and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ScanSource with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of ScanSource and Inhibrx.
Diversification Opportunities for ScanSource and Inhibrx
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between ScanSource and Inhibrx is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding ScanSource and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and ScanSource is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ScanSource are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of ScanSource i.e., ScanSource and Inhibrx go up and down completely randomly.
Pair Corralation between ScanSource and Inhibrx
Given the investment horizon of 90 days ScanSource is expected to generate 0.35 times more return on investment than Inhibrx. However, ScanSource is 2.83 times less risky than Inhibrx. It trades about 0.18 of its potential returns per unit of risk. Inhibrx is currently generating about -0.17 per unit of risk. If you would invest 4,905 in ScanSource on October 26, 2024 and sell it today you would earn a total of 216.00 from holding ScanSource or generate 4.4% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
ScanSource vs. Inhibrx
Performance |
Timeline |
ScanSource |
Inhibrx |
ScanSource and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ScanSource and Inhibrx
The main advantage of trading using opposite ScanSource and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ScanSource position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.ScanSource vs. Climb Global Solutions | ScanSource vs. Insight Enterprises | ScanSource vs. Synnex | ScanSource vs. PC Connection |
Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |